GT BIOPHARMA, INC. Shares Outstanding (Cover Page)
GT BIOPHARMA, INC. (GTBP) had Shares Outstanding (Cover Page) of 45.11 million shares as of 2026-08-10, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-14
- 2026-08-10: Entity Common Stock, Shares Outstanding 45.11M shares.
- 2026-05-08: Entity Common Stock, Shares Outstanding 36.06M shares.
- 2026-02-23: Entity Common Stock, Shares Outstanding 31.55M shares.
- 2025-11-06: Entity Common Stock, Shares Outstanding 10.64M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-10 | 45.11M shares 10-Q · filed 2026-08-14 |
| 2026-05-08 | 36.06M shares 10-Q · filed 2026-05-15 |
| 2026-02-23 | 31.55M shares 10-K · filed 2026-03-02 |
| 2025-11-06 | 10.64M shares 10-Q/A · filed 2026-03-06 |
| 2025-08-08 | 3.56M shares 10-Q/A · filed 2026-03-06 |
| 2025-05-13 | 2.59M shares 10-Q · filed 2025-05-15 |
| 2025-02-19 | 2.23M shares 10-K/A · filed 2025-04-14 |
| 2024-11-10 | 2.23M shares 10-Q · filed 2024-11-14 |
| 2024-08-10 | 2.23M shares 10-Q · filed 2024-08-14 |
| 2024-05-15 | 1.42M shares 10-Q · filed 2024-05-15 |
| 2024-03-26 | 1.38M shares 10-K · filed 2024-03-26 |
| 2023-11-01 | 41.42M shares 10-Q · filed 2023-11-01 |
| 2023-08-07 | 40.64M shares 10-Q · filed 2023-08-07 |
| 2023-05-15 | 37.43M shares 10-Q · filed 2023-05-15 |
| 2023-03-30 | 36.81M shares 10-K · filed 2023-03-30 |
| 2022-10-31 | 32.56M shares 10-Q · filed 2022-10-31 |
| 2022-08-15 | 31.09M shares 10-Q · filed 2022-08-15 |
| 2022-05-16 | 30.50M shares 10-Q · filed 2022-05-16 |
| 2022-03-28 | 32.12M shares 10-K · filed 2022-03-28 |
| 2021-11-12 | 30.58M shares 10-Q · filed 2021-11-10 |
| 2021-08-15 | 30.48M shares 10-Q/A · filed 2021-12-29 |
| 2021-05-12 | 21.13M shares 10-Q · filed 2021-05-17 |
| 2021-04-12 | 28.39M shares 10-K · filed 2021-04-16 |
| 2020-11-11 | 78.27M shares 10-Q · filed 2020-11-13 |
| 2020-08-11 | 76.56M shares 10-Q/A · filed 2020-08-18 |
| 2020-05-12 | 70.70M shares 10-Q · filed 2020-05-15 |
| 2020-03-23 | 70.60M shares 10-K · filed 2020-03-27 |
| 2019-11-14 | 67.43M shares 10-Q · filed 2019-11-14 |
| 2019-08-11 | 66.14M shares 10-Q · filed 2019-08-14 |
| 2019-05-11 | 51.37M shares 10-Q · filed 2019-05-15 |
| 2019-03-06 | 51.37M shares 10-K · filed 2019-03-29 |
| 2018-11-14 | 50.23M shares 10-Q · filed 2018-11-14 |
| 2018-08-14 | 50.12M shares 10-Q · filed 2018-08-14 |
| 2018-05-11 | 50.12M shares 10-Q · filed 2018-05-15 |
| 2018-02-28 | 50.12M shares 10-K · filed 2018-03-01 |
| 2017-11-14 | 49.77M shares 10-Q · filed 2017-11-14 |
| 2017-08-11 | 496.44K shares 10-Q · filed 2017-08-11 |
| 2017-04-28 | 144.71M shares 10-Q · filed 2017-04-28 |
| 2017-03-28 | 122.91M shares 10-K/A · filed 2018-02-28 |
| 2016-11-14 | 30.24M shares 10-Q/A · filed 2018-02-28 |
| 2016-08-01 | 26.92M shares 10-Q/A · filed 2018-02-28 |
| 2016-05-13 | 22.43M shares 10-Q/A · filed 2018-02-28 |
| 2016-03-27 | 21.52M shares 10-K/A · filed 2018-02-28 |
| 2015-11-13 | 600.00M shares 10-Q · filed 2015-11-13 |
| 2015-08-14 | 600.00M shares 10-Q · filed 2015-08-14 |
| 2015-05-14 | 600.00M shares 10-Q · filed 2015-05-14 |
| 2015-03-27 | 599.91M shares 10-K · filed 2015-03-31 |
| 2015-01-08 | 591.71M shares 10-K · filed 2015-01-08 |
| 2015-01-07 | 591.71M shares 10-Q · filed 2015-01-08 |
| 2014-12-15 | 591.71M shares 10-Q · filed 2014-12-17 |
| 2014-12-12 | 591.71M shares 10-Q · filed 2014-12-12 |
| 2014-12-05 | 591.71M shares 10-Q · filed 2014-12-10 |
| 2014-10-23 | 591.71M shares 10-K · filed 2014-11-18 |
| 2012-09-30 | 457.21M shares 10-Q · filed 2012-11-21 |
| 2012-06-30 | 364.30M shares 10-Q/A · filed 2012-09-13 |
| 2012-05-15 | 329.80M shares 10-Q · filed 2012-05-21 |
| 2012-04-13 | 269.30M shares 10-K · filed 2012-04-16 |
| 2011-11-21 | 238.62M shares 10-Q · filed 2011-11-21 |
| 2011-08-15 | 215.42M shares 10-Q/A · filed 2011-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |